INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹428 Cr | ₹343 Cr | ₹314 Cr | ₹165 Cr | ₹85 Cr |
What is the latest Net Current Assets ratio of INNOVA CAPTAB ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹428 Cr |
| Mar2025 | ₹343 Cr |
| Mar2024 | ₹314 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹85 Cr |
How is Net Current Assets of INNOVA CAPTAB Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹428 Cr | 25.01 | |
| Mar2025 | ₹343 Cr | 9.04 | |
| Mar2024 | ₹314 Cr | 90.56 | |
| Mar2023 | ₹165 Cr | 95.09 | |
| Mar2022 | ₹85 Cr | - | |
Compare Net Current Assets of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,694.0 Cr | 6.1% | 17.4% | 10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 6.1% |
17.4% |
10.8% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses